Sep 7, 2001
Guidant to Host Briefing at the Transcatheter Cardiovascular Therapeutics Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a briefing at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C. The briefing, which will be webcast live, will take place on Friday, Sept. 14, from 8 a.m. to 9:15 a.m. (EDT). The session, hosted by Ronald W. Dollens, president and CEO of Guidant, and John M. Capek, Ph.D., president, Vascular Intervention, Guidant, will feature a discussion of Guidant's drug-coated stent program and vascular intervention business followed by a panel discussion. Scheduled presenters for the panel are Patrick Serruys, M.D., Thoraxcenter, Rotterdam; Renu Virmani, M.D., Armed Forces Pathology Institute; Alan Heldman, M.D., assistant professor of medicine, Johns Hopkins University, and Thomas Linnemeier, M.D., Guidant senior vice president and chief medical officer.

The live webcast of Guidant's briefing will be accessible to all investors through Guidant's website or on StreetFusion.com. The webcast will be archived on both websites for future on-demand replay.

System requirements for the webcast include Internet Explorer 5.0 (or higher) or Netscape Navigator 4.0 (or higher). Users also should have the most recent version of Windows Media Player, which can be downloaded for free. Users may experience varying levels of performance based on their connection speed, system capabilities and presence of a corporate firewall.

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to 7 million cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions.